Global Health Ventures appoints Lola Maksumova COO
This article was originally published in Scrip
Executive Summary
Global Health Ventures, a speciality pharmaceutical company with a focus on sublingual drug delivery, has appointed Dr Lola Maksumova senior vice-president and chief operating officer. Dr Maksumova was previously vice-president of drug development at Pacific Therapeutics.